8-KLeadership ChangesExhibits & Filings

BANK OF AMERICA CORP /DE/ 8-K Report, Executive Changes (Oct 24, 2018)

Summary

This 8-K filing by Bank of America Corporation (BAC) announces a change in its Board of Directors. Effective immediately, Dr. Clayton S. Rose has been appointed to the Board and will serve on both the Audit and Compensation and Benefits Committees. Dr. Rose's appointment is significant as he brings his experience as the president of Bowdoin College to the company's governance structure. Investors should note that Dr. Rose will be compensated as a non-employee director according to the company's established program, which includes restricted stock and cash awards. This appointment is a governance-related event and does not reflect immediate financial performance changes, but it signals ongoing adjustments to the company's leadership and oversight. The filing also includes a furnished news release as an exhibit, providing further details on the appointment.

Key Highlights

  • 1Dr. Clayton S. Rose appointed to Bank of America's Board of Directors, effective October 24, 2018.
  • 2Dr. Rose appointed to the Board's Audit Committee.
  • 3Dr. Rose appointed to the Board's Compensation and Benefits Committee.
  • 4Dr. Rose's compensation will follow the standard non-employee director program.
  • 5Compensation includes restricted stock and cash awards, prorated from appointment date.
  • 6The appointment is detailed in an accompanying news release furnished as an exhibit.

Frequently Asked Questions

Dr. Clayton S. Rose is the president of Bowdoin College. He has been appointed to Bank of America's Board of Directors, bringing his experience in leadership and education to the company's governance.

Dr. Rose has been appointed to serve on the Board's Audit Committee and the Compensation and Benefits Committee.

Dr. Rose will receive compensation as a non-employee director in accordance with Bank of America's established program. This compensation will include restricted stock and cash awards, which will be prorated from his appointment date until the next annual stockholders' meeting.

This filing primarily concerns a governance change with the appointment of a new director. It does not directly report on financial performance. However, the addition of experienced individuals to the Board is generally seen as a positive step for corporate oversight.